Blockchain Registration Transaction Record

Clene Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Clene Inc. and its subsidiary, Clene Nanomedicine Inc., to present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor meetings. The company is focused on improving mitochondrial health to treat neurodegenerative diseases, including ALS and MS.

This news matters as it highlights a clinical-stage biopharmaceutical company's efforts to develop innovative therapies for neurodegenerative diseases like ALS and MS. The presentation at the conference provides an opportunity for investors to learn about Clene Inc.'s promising developments in the field of mitochondrial health and neuronal function protection.